Resultados de la búsqueda 651-660 of 4170 for AM - PM
... are safe for people to take. We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab ...
These include but are not limited to improvements in: (i) receiver coils; (ii) pulse sequences for data acquisition; (iii) methods for image reconstruction ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
22, 2025, 02:00 p.m. CDT · Mayo Clinic Q&A: When to ... 12, 2024, 11:00 a.m. CDT · Mayo Clinic again earns ... 28, 2024, 09:57 p.m. CDT · Closing the ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Devices used for microperfusion are Joanneum Research's cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump.
Rochester, Minn. The aims of this study are to investigate the presence of tumor cells after filtration of autologous blood products by intraoperative cell ...
The names of the study drugs involved in this study are ... The aim of this study is to use the combine clinical risk assessment models that are ...
The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?